Gliucofaj coated tablets 500 mg. №30

$11.00

Manufacturer: France

Purpose: Lowers blood sugar levels in type 2 diabetes by increasing insulin sensitivity.

SKU: MED58720 Category:

Description

Gliucofaj Coated Tablets 500 mg. №30

Ingredients:

Each coated tablet contains 500 mg of Glucophage (Metformin Hydrochloride).

Mechanism of Action:

Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity, leading to lower blood glucose levels.

Pharmacological Properties:

Metformin, the active ingredient in Gliucofaj tablets, is a biguanide that improves glucose utilization and reduces hyperglycemia.

Indications for Use:

Gliucofaj coated tablets are indicated for the treatment of type 2 diabetes mellitus to control blood sugar levels and prevent complications.

Contraindications:

Avoid Gliucofaj tablets if you have severe kidney disease or metabolic acidosis. Consult a healthcare professional before starting this medication.

Side Effects:

Common side effects may include gastrointestinal disturbances, such as nausea and diarrhea. Rare side effects include lactic acidosis.

Usage Instructions:

Take one tablet orally with meals once or twice daily, as prescribed by a healthcare professional. Swallow the tablet whole with water; do not crush or chew.

Benefits Compared to Analogues:

Gliucofaj offers effective blood glucose control with proven cardiovascular benefits, making it a preferred choice in managing type 2 diabetes.

Suitable Patient Groups:

Gliucofaj is suitable for adults with type 2 diabetes. Dosage adjustments may be necessary for elderly patients or those with hepatic impairment.

Storage and Shelf Life:

Store Gliucofaj tablets in a cool, dry place below 25°C. Check the expiration date on the packaging and do not use after the specified date.

Packaging Description:

Gliucofaj tablets are packaged in blister packs of 30 tablets each, ensuring protection from light and moisture.

Scientific Evidence:

Studies have shown that Metformin effectively reduces blood glucose levels by improving insulin sensitivity and decreasing hepatic glucose production.

Research in the Journal of Clinical Investigation highlights Metformin’s long-term benefits in reducing cardiovascular risk factors in type 2 diabetes patients.

Additional Information:

Regular monitoring of blood sugar levels is crucial while taking Gliucofaj to optimize dosage adjustments. Inform your healthcare provider about all medications to prevent potential drug interactions.